4.7 Article

Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2

Journal

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 30, Issue 2, Pages 277-292

Publisher

AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2018080815

Keywords

immunology; ischemia-reperfusion; T cells

Funding

  1. NIH [R01-DK104662]

Ask authors/readers for more resources

Background CD42 CD82 double-negative (DN) ab T cells with innate-like properties represent a significant component of T cells in human andmouse kidneys. They spontaneously proliferate in the steady state and protect against ischemic AKI. However, the mechanisms regulating DN T cell homeostasis and responses to external danger signals from sterile inflammation remain poorly understood. MethodsWe used knockoutmice, functional assays, and an established ischemic AKI model to investigate the role of various MHC class I and II molecules in regulating kidney DN T cells. We also studied human nephrectomy samples. Results Deficiency of b2m-dependent MHC class I (but not MHC class II) molecules led to significant reduction in frequency or absolute numbers of kidney DN T cells due to impaired activation, proliferation, increased apoptosis, and loss of anNK1.1(+) subset ofDNT cells. The remaining DNT cells in b2mknockout mice mainly comprised a programmed cell death protein-1 receptor (PD-1(+)) subset that depends on IL-2 provided by conventional T cells for optimal homeostasis. However, this PD-1(+) subset remained highly responsive to changes inmilieu, demonstrated by responses to infused lymphocytes. It was also themajor responder to ischemic AKI; theNK1.1(+) subset and CD8(+) T cells hadminimal responses. We found bothDN T cell subsets in normal and cancerous human kidneys, indicating possible clinical relevance. Conclusions DN T cells, a unique population of kidney T cells, depend on nonclassical b2m molecules for homeostasis and use MHC-independent mechanisms to respond to external stimuli. These results have important implications for understanding the role these cells play during AKI and other immune cell-mediated kidney diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available